ARCHIVES

Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors

This article is from The Cancer Letter archive.

Vol. 37 No. 25 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Toxicity Of Salts Regimen Should Remain A Concern.

January 4, 2002

Conferees Set NIH Funding At $30 Billion.

November 2, 2007

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999